Boehringer Ingelheim US News and Activities

Boehringer Ingelheim US is owned by Boehringer Ingelheim. Boehringer Ingelheim has a direct presence in 15 countries.

Boehringer Ingelheim has 16 subsidiaries including Boehringer Ingelheim Animal Health USA, Boehringer Ingelheim Asia and Boehringer Ingelheim Belgium.

View the org chart displaying its 15 main executives

Most searched biographies at Boehringer Ingelheim US

• Jean-Michel Boers, Country Managing Director, President and Chief ...
• Lars Dreesmann, Head, Launch and Innovation
• Amy Rudolph, Head Global Medical Affairs

Popular executive movements at Boehringer Ingelheim US

• Christie Bloomquist has joined the company as Senior Vice President, Corporate Affairs, Human Pharma, USA  (posted on April 29 2026).

Popular executive movements at Boehringer Ingelheim

• Mohammed Tawil, who was Chairman and Chief Executive Officer, Hong Kong and Taiwan, is promoted to Senior Vice President, Head of Emerging Markets  (posted on April 20 2026).
• Harsha Deshmukh will join the company as Director, Information Technology and Global Business Services on Feb. 1, 2026  (posted on December 1 2025).

Create your alert
to follow the executive moves at Boehringer Ingelheim US.

Boehringer Ingelheim has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Boehringer Ingelheim US

• Novel antibody shows potential to transform treatment of rare form of psoriasis | boehringer-ingelheim.us
• Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride | boehringer-ingelheim.us
• Everett Hoekstra Appointed President of Boehringer Ingelheim Animal Health USA Inc. | boehringer-ingelheim.us
• The maker of HEARTGARD® Plus (ivermectin/pyrantel) launches initiative to combat rising incidence rates of heartworm disease | boehringer-ingelheim.us
• Boehringer Ingelheim Announces Winners of 2018 Champions of the Cause Awards | boehringer-ingelheim.us
• Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna | boehringer-ingelheim.us
• Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders | boehringer-ingelheim.us
• Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease | boehringer-ingelheim.us
• Researchers focused on infectious respiratory disease in pigs may apply for Boehringer Ingelheim research awards | boehringer-ingelheim.us
• What You Should Know About Coliform Mastitis | boehringer-ingelheim.us
• View more press releases Close

Social media about Boehringer Ingelheim US

• Boehringer Ingelheim US on Wikipedia, Google News & Yahoo Finance
• Boehringer Ingelheim US on LinkedIn, X (Twitter) & YouTube